The 4th annual Pharma Pricing & Market Access Outlook is the World’s largest pricing, reimbursement and market access event for the pharmaceutical and biotech community.
Late Phase Drug Development World Americas 2010 is the first ever strategic forum addressing the major challenges in conducting strategic and compliant late stage studies for pharmaceutical and biotech companies.
The 2nd annual World Drug Safety Congress Americas addresses the key challenges for drug safety & pharmacovigilance professionals Worldwide. We address the crucial issues in the development and execution of drug safety programmes.
Europe’s largest and most influential early development / phase I congress will address the critical issues in achieving seamless first in man studies and will provide advice on conducting effective studies that allow you to make the right decision early on in clinical development
The 4th annual World Drug Safety Congress in Europe addresses the key challenges for drug safety professionals Worldwide. The World Drug Safety Congress addresses the crucial issues in the development and execution of drug safety programmes.
DigiPharm Europe 2010 is one of the largest gatherings of pharmaceutical marketing and communications professionals in Europe. Benchmark strategies to enhance online communication, customer relations, brand awareness and profitability in digital marketing.
Market Access World USA will attract a record number of pharma market access thought leaders. This event will provide delegates with the most comprehensive review of US health reform.
The 3rd annual Exploratory Clinical Development World Americas follows the huge success of the inaugural conference in September 2008, to which Health Network attracted a record number of early development scientists and decision makers to explore the challenges of Phase I trials.
World Generic Medicines Congress Americas 2010 addresses the health economics, pricing and competition pressures facing the generics sector in Europe and building scale and value through globalisation.
The 2nd annual Late Phase Drug Development World 2010 is the first ever strategic forum addressing the major challenges in conducting strategic and compliant late stage studies for pharmaceutical and biotech companies.
Health Technology Assessment World Europe 2010 is the 3rd annual policy forum for the industry where all the major HTA agencies across the world and leading pharmaceutical companies discuss the challenges in obtaining market access.
